Drug intelligence / Profile preview

Pyr3

Development stage
Unknown
Modality
Small Molecules
Administration
Not Applicable (used In Vitro/in Vivo Preclinical Research Settings)
01

Overview

Pyr3 is a selective small molecule inhibitor of the canonical transient receptor potential channel 3 (**TRPC3**), used primarily in research settings to block TRPC3-mediated calcium influx (IC50 ~0.7 μM), resulting in inhibition of downstream calcium-dependent signaling pathways. It suppresses activation of nuclear factor of activated T cells (NFAT) and inhibits hypertrophic responses in cardiomyocytes. Pyr3 is not an approved pharmaceutical; it is most commonly applied in cardiovascular, neuronal, and smooth muscle cell biology studies to dissect TRPC3 function[1][2][3][8].

Other names
1-[4-[(2,3,3-Trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acidethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
02

Targets

TRPC3ORAI1 (Calcium release–activated calcium channel protein 1)

Beyond the preview

Go deeper on Pyr3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyr3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call